NAUČNI KARTON UPOSLENIKA

Similar documents
NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj

NAUČNI KARTON UPOSLENIKA

Fuad Džanković IME I PREZIME: DATUM I MJESTO ROĐENJA: docent AKADEMSKO ZVANJE: FAKULTET: Sveučilište Vitez Vitez MAGISTARSKI: DOKTORAT:

NAUČNI KARTON UPOSLENIKA Institut za naučnoistraživački rad i razvoj

Prezime (ime roditelja) i ime Naučni stepen/zvanje. Hasanbegović (Salko) Edo. Datum rođenja Država, mjesto i općina rođenja Organizaciona jedinica

Applications of IHC. Determination of the primary site in metastatic tumors of unknown origin

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Personal details: Qualifications:

The Pathology of Neoplasia Part II

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

Somatostatin receptor SSTR2A and SSTR5 in neuroendocrine breast cancer

Angiogenesis in triple-negative adenoid cystic carcinomas of the breast

Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67

NAUČNI KARTON UPOSLENIKA

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

Oncology 101. Cancer Basics

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology

Cancer: recent advances and implications for underwriting

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

MEDICAL POLICY Gene Expression Profiling for Cancers of Unknown Primary Site

10/15/2012. Biologic Subtypes of TNBC. Topics. Topics. Histopathology Molecular pathology Clinical relevance

Review of NEO Testing Platforms. Lawrence M. Weiss, MD Medical Director, Aliso Viejo

MEDICAL POLICY. Proprietary Information of YourCare Health Plan

Recent advances in breast cancers

Introduction and illustration of the OECI study proposal/feedback of the survey on outcome studies Milena Sant, MD

Tumor Markers & Cytopathology

Measles and rubella monitoring January 2015

Case 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset

Barriers to Understanding

Sumida T, Hamakawa H. Telomerase and oral cancer. Oral Oncol. 37(4): ,

Cutaneous metastases. Thaddeus Mully. University of California, San Francisco Professor, Departments of Pathology and Dermatology

Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine

Tumor Markers Yesterday, Today & Tomorrow. Steven E. Zimmerman M.D. Vice President & Chief Medical Director

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Summary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

A CASE OF PRIMARY THYROID LYMPHOMA. Prof Dr.Dilek Gogas Yavuz Marmara University School of Medicine Endocrinology and Metabolism Istanbul, Turkey

NEW IHC A n t i b o d i e s

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

PAAF vs Core Biopsy en Lesiones Mamarias Case #1

Localized Prostate Cancer Have we finally got it right? Shingai Mutambirwa Professor & Chair-Division Urology DGMAH & SMU Pretoria SOUTH AFRICA

Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016

Claudin-4 Expression in Triple Negative Breast Cancer: Correlation with Androgen Receptors and Ki-67 Expression

List of Available TMAs in the PRN

Institute for Cancer Genetics and Informatics

Quality Control/Quality Assurance in Diagnostic Immunohistochemistry

Mu ath M.A. Rjoub Supervised by: Dr. Huda Zahawi, FRCPath. King Abdullah University Hospital )KAUH(

Immunohistochemical classification of lung carcinomas and mesotheliomas. Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark

Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

Monitoring Metastatic Breast Cancer with Serum HER-2/neu: Individual Patient Profiles

The European Commission s science and knowledge service. Joint Research Centre

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

ACCME/Disclosures. Case History 4/13/2016. USCAP GU Specialty Conference Case 3. Ann Arbor, MI

2018 Surgical Pathology Update: Diagnostic Pearls for the Practicing Pathologist - Volume II

IBCM 2, April 2009, Sarajevo, Bosnia and Herzegovina

A 53 year-old woman with a lung mass, right hilar mass and mediastinal adenopathy.

Breast pathology. 2nd Department of Pathology Semmelweis University

NAUČNI KARTON ZDRAVSTVENIH RADNIKA I ZDRAVSTVENIH SURADNIKA KCUS-A

Cancer Mortality, Recent Trends And Perspectives

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Cleveland Clinic Laboratories. Anatomic Pathology

ACCME/Disclosures. Diagnosing Mesothelioma in Limited Tissue Samples. Papanicolaou Society of Cytopathology Companion Meeting March 12 th, 2016

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Carcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS

Case 4 Diagnosis 2/21/2011 TGB

NPQR Quality Payment Program (QPP) Measures 21_18247_LS.

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e.

Triple Negative Breast Cancer

The role of the cytologist in breast cancer screening

RSNA, /radiol Appendix E1. Methods

Surgical Oncology/Clinical Center Sarajevo - Sarajevo, Bosnia and Herzegovina

CODING TUMOUR MORPHOLOGY. Otto Visser

Diploma Examination. Dermatopathology: First paper. Tuesday 20 March Candidates must answer FOUR questions. Time allowed: 3 hours

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

Problems in staging breast carcinoma

RESPIRATORY SOCIETY IN BOSNIA AND HERZEGOVINA Bardakčije 90, Sarajevo, Bosnia i Herzegovina

Enterprise Interest None

Clinical indications for positron emission tomography

Identification of Potential Therapeutic Targets by Molecular and Genomic Profiling of 628 Cases of Uterine Serous Carcinoma

Case 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:

Surgical Pathology Lab of the Future. Thomas M. Grogan, M.D. Professor of Pathology, University of Arizona Founder, Ventana Medical Systems, Inc.

Molecular Characterization of Breast Cancer: The Clinical Significance

Diploma examination. Dermatopathology: First paper. Tuesday 21 March Candidates must answer FOUR questions ONLY. Time allowed: Three hours

Quality Assurance and Quality Control in the Pathology Dept.

Transcription:

1. Osnovni podaci Prezime Univerzitetski klinički centar u Sarajevu NAUČNI KARTON UPOSLENIKA BILALOVIĆ Institut za naučnoistraživački rad i razvoj Ime NURIJA Godina rođenja 1962 Mjesto rođenja Država rođenja Zvanje Titula E mail Trebinje Bosna i Hercegovina Doktor medicine, Doktor medicinskih nauka, specijalista patolog Docent nurija62@gmail.com Telefon/Faks 033 29 85 09/033 29 78 26 Telefon lokal 8509 Organizaciona jedinica - Disciplina UKC Klinička patologija i citologija Dijagnostička disciplina 2.Podaci o stečenim diplomama Godina Mjesto Naziv rada Fakultet/Univerzitet Naučna oblast Diploma 1987 Sarajevo Med.fak/UNSA Magisterij 2002. Sarajevo Značaj imunohistohemije i kliničkih podataka u dijagnostici malignih limfoma klasificiranih po R.E.A.L.- Med.fak/UNSA Hematologija Doktorat 2004. Sarajevo Uloga transkriptivnog faktora PU.1 u folikularnom limfomu. Med.fak/UNSA Hematologija Godina Mjesto Naziv Specijalizacija 1998 Sarajevo Anatomska patologija Subspecijalizacija 1

3.Podaci o izborima u nastavničko/saradničko zvanje (navoditi od posljednjeg izbora u zvanje) Godina izbora Naziv zvanja Fakultet/Univerzitet Predmet Naučna oblast 2014 Docent SSST Medical School Histologija i Embriologija Histologija i Embriologija 2010 Docent Fakultet zdravstvenih studija Banja Luka/ Panevropski Univerzitet Apeiron Osnovi patologije Patologija 2010 Docent Fakultet zdravstvenih studija Sarajevo/ Univerzitet Sarajevo 2003 Viši asistent Medicinski fakultet, Univerziteta u Sarajevu. Disfunkcija ljudskog organizma Institut i katedra za patologiju Patologija Institut i katedra za patologiju 4. Usmjerena/kontinuirana edukacija (naziv, trajanje, godina, mjesto) Godina Mjesto Trajanje Naziv 1995 Institutu za patologiju Zagreb, Medicinsko Sveučilište 1995 Onkološki Institut, odjel za patologiju-ljubljana 1999 Copenhagen, Univerzitetska bolnica Herlev 1997 Onkološki Institut, odjel za patologiju-ljubljana 2000 Onkološki Institut, odjel za patologiju-ljubljana 2002 Onkološki Institut, odjel za patologiju-ljubljana 2002 The Radium Hospitale Oslo 2002/2003 The Radium Hospitale Oslo 4 mjeseca Edukacija iz patologije u sklopu specijalizacije 1 mjesec Edukacija iz patologije u sklopu specijalizacije 3 mjeseca Edukacija iz hematopatologije pod mentorstvom prof dr Elisabeth Ralfkiær 1 mjesec Edukacija iz hematopatologije pod mentorstvom dr Janez Jancar 1 mjesec Edukacija iz hematopatologije pod mentorstvom dr Andrea Zidar 1 mjesec Edukacija iz hematopatologije pod mentorstvom dr Janez Jancar i dr Andrea Zidar 3 mjeseca Gost The Radium Hospitale Oslo, edukacija iz hematopatologije mentori Prof dr Jahn Delabie i Dr. Emina Torlaković 7 mjeseci Stipendista Norveške vlade, Istraživačkog vijeća Norveške iz oblasti hematopatologije 2

5. Objavljeni radovi (navoditi od posljednjeg objavljenog rada) 5.1 Originalni/naučni radovi 1. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Branzovsky J, Michal M, Hes O. Cystic renal oncocytoma and tubulocystic renal cell carcinoma: Morphologicaland immunohistohemical study. Pathology 2014;46(S2):135-6. 2. Konjhodzic R, Dervovic E, Kurtovic-Basic I, Stomornjak-Vukadin M, Muhic A, Baljevic S, Pirnat-Gegic A, Basic E, Bilalovic N. Use of Quantitative Fluorescent Polymerase Chain Reaction (QF PCR) in Prenatal Diagnostic of Fetal Aneuploidies in a 17 Month Period in Parallel with Karyotyping.Acta Inform Med. 2014 Apr;22(2):86-8. 3. Godinjak Z, Bilalovic N.Estrogen and progesterone receptors in endometrium in women with unexplained infertility. Mater Sociomed. 2014 Feb;26(1):51-2. 4. Foco F, Bilalović N, Vranić S, Serdarević F, Ramović I, Imamović E.Peritumoral p53 expression in oral carcinoma. Coll Antropol. 2012 Nov;36 Suppl 2:129-32. 5. Godinjak Z, Bilalović N, Idrizbegović E. Laparoscopic treatment of ovarian dermoid cysts is a safe procedure. Bosn J Basic Med Sci. 2011 Nov;11(4):245-7. 6. Vranic S, Frkovic-Grazio S, Bilalovic N, Gatalica Z. Angiogenesis in adenoid cystic carcinoma of the breast. Virchows Arch 2011;459:377-82 7. Kozarić-Kurtović A, Bilalović N, Gavrankapetanović F. Razvoj citogenetike i molekularne genetike u medicinskoj dijagnostici na Kliničkom Centru Univerziteta u Sarajevu. Med Žurnal 2010; 16 (4, Suppl.1):31-37 8. Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, Bilalovic N, Lee LMJ, Gatalica Z. Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently over-express EGFR protein without EGFR gene amplification. Hum Pathol 2010;41:1617-23 9. Vranic S, Tawfik O, Palazzo J, Bilalovic N, Eyzaguirre E, Lee LMJ, Adegboyega P, Hagenkord J, Gatalica Z. EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast. Mod Pathol 2010;23:644-53. 10. Kundurović Z, Hasanagić S, Bilalović N, Gavrankapetanović F, Aličelebić S. Pro-apoptotic protein Bax and antiapoptic protein Bcl-2 expression in streptozotocin model of Alzheimer s disease. HealthMED 2009; 3(4):520-528. 11. Vranic S, Caughron SK, Djuricic S, Bilalovic N, Zaman S, Suljevic I, Lydiatt WM, Emanuel J, Gatalica Z. Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinicopathologic correlation, cytogenetic analysis, and review of the literature.bmc Ear Nose Throat Disord. 2008;8:8 12. Cukić V, Lovre V, Beslić S, Bilalović N, Guska S.Lung lymphangioleiomyomatosis (LAM). Med Arh. 2008;62(3):180-2 13. Torlakovic EE, Slipicevic A, Flørenes VA, Chibbar R, DeCoteau JF, Bilalovic N. Fli-1 expression in malignant melanoma. Histol Histopathol. 2008 Nov;23(11):1309-14. 14. Sofic A, Sehovic N, Beslic S, Prnjavorac B, Bilalovic N, Caluk J, Sofic D MR rectum imaging with ultra sound gel as instrumental contrast media in tubulovillous adenomaso RADIOLOGY AND ONCOLOGY VL 42 IS 3 BP 136 EP 142 PY 2008 TC 1 15. Foco F, Vranic S, Serdarevic F, Cickusic E, Bilalovic N. Peritumoral expression of p53 protein in oral carcinoma and its correlation with relapse. Med Zurnal 2007;13:95-99. 16. Vranić S, Bilalović N, Lee LMJ, Krušlin B, Lilleberg S, Gatalica Z. PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney. Hum Pathol 2007;38:1425-31 17. Vukobrat-Bijedić Z, Husić-Selimović A, Radović S, Gornjaković S, Gogov B, Zubcević N, Bilalović N, Koluder. Evaluation of hepatitis C virus genotype and its influence on therapeutical respond on combined therapy with pegilated interferon A 2a (40)kD and ribavirin. Med Arh. 2007;61(4):221-3. 3

18. Prohic A, Selmanagic A, Bilalovic N. Epidermolytic Hyperkeratosis Type NPS-3: A Case Report. Acta Dermatovenerol Croat. 2007;15(1):20-3. 19. Junuzović Dž, Kulovac B, Bilalović N, Bajramović S.PRESERVATION OF RENAL FUNCTION BY EARLY DIAGNOSIS AND TREATMENT OF URETERAL OBSTRUCTION DUE TO IDIOPATHIC RETROPERITONEAL FIBROSIS. Medicinski Žurnal 2007; 13 (3-4):152-155. 20. Balta E; Beslic N; Bilalovic N; Beslic Sefik; Secic S; KapetanovicE; Muftic K. SLN operativna tehnika malignih tumora dojke. ACTAINFORMATICA MED. 2006; 14(2): 83-87. 21. Vranic S, Kapur L, Foco F, Bilalovic N, Hainaut P. The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: Case report. Pathologica 2006;98 22. Torlakovic EE, Bilalovic N, Golouh R, Zidar A, Angel S. Prognostic significance of PU.1 in follicular lymphoma. J Pathol. J Pathol. 2006 Jul;209(3):352-9 J Pathol. 2006 Jul;209(3):352-9. 23. Bilalovic N, Vranic S, Serdarevic F, Foco F. The role of the stroma in carcinogenesis. Bosn J Basic Med Sci 2006;6(1):33-8 24. Lacevic A, Bilalovic N, Kapic A.Bacterial aggregation in infected root canal. Bosn J Basic Med Sci. 2005 Nov;5(4):35-9. 25. Bilalovic N, Vranic S, Basic H, Tatarevic A, Selak I. Immunohistochemical evaluation of cyclin D1 in breast cancer.croat Med J. 2005 Jun;46(3):382-8 26. Bilalović N,Vranić S, Hasanagić S, Bašić H, Tatarevic A, Bešlija S, Selak I. The Bcl-2 protein: a prognostic indicator strongly related to ER and PR in breast cancer. Bosnian Journal of basic medical sciences. 2004; 4: 5-12. 27. Torlakovic E, Bilalovic N, Nesland JM., Torlakovic G, Florenes V. ETS-1 transcription factor is widely expressed in benign and malignant melanocytes and has no association with prognosis. Mod Pathol. 2004;17:1400-6. 28. Bilalovic N., Blystan A.K., Golouh R., Nesland J.M., Selak I., Trinh D., Torlakovic E. BCL-6 and CD10 protein expression are associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol. 2004;121:34-42. 29. Bilalovic N., Sandstad B., Golouh R., Nesland J.M., Selak I., Torlakovic E. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol. 2004;17:1251-8. 30. Selak I, Bilalovic N, Vranic S, Sabanovic E. Malignant Lymphoma in SarajevoRegion according to WHO Classification in periods 1989-1991 (before the war)and 1997-1999 (after the war). Radovi Akademije nauka i umjetnosti Bosne I Hercegovine 2003;31:131-50 31. Vuckovic I, Dilberovic F, Kapur E, Voljevica A, Bilalovic N, Selak I. The principles of telemedicine in practice. Bosnian Journal of basic medical sciences. 2003; 4: 54-60. 32. MAŠIC I, BILALOVIC N, KARCIC S, HADŽIAHMETOVIC Z. Korijeni telemedicine u Bosni i Hercegovini u postdejtonskom periodu. Mat Soc Med, 2002; 14(3-4): 107-10. 33. Bilaloviċ N., Vidoviċ Z., Telemedicine with respect to telepathology in Bosnia-Herzegovina. Med Arh 1999;53:69-72. 34. Vidoviċ Z., Bilaloviċ N., Telemedicine with emphasis on telepathology--its beginnings and future prospects in Bosnia-Herzegovina. Med Arh. 1998;52:215-8. 35. Mornjakoviċ Z., Aličelebiċ S., Bilaloviċ N., Šuško I., Morphometric characteristics of Leydig cells in rats treated with melatonin and whole body irradiation. Med Arh 1998;52:183-184. 36. Bilaloviċ N., Paties C., Mason A., SHARED ( Satelite Health Access for Remote Environment Demonstrator) project in Bosnia and Herzegovina: benefits of using telemedicine and first results. Journal of Telemedicine and Telecare 1998;4:91-3. 37. Vidoviċ Z., Bilaloviċ N., Telepathology and present experience based on use of the SHARED telecommunication project. Med Arh 1997;51:99-102. 4

38. Selak I., Bilaloviċ N. Concept of Telepathology in R/F Bosnia and Herzegovina, Electronic Journal of Pathology and Histology.1996;2:963 39. Vidoviċ Z., Bilaloviċ N., Babiċ M., Selak I., Šimiċ S., Carcinoma of sweat gland vulve, Med Arh 1996;2:40-43. 40. 5.2 Stručni radovi 1. Konjhodzic R, Dervovic E, Kurtovic-Basic I, Stomornjak-Vukadin M, Muhic A, Baljevic S, Pirnat-Gegic A, Basic E, Bilalovic N. Use of Quantitative Fluorescent Polymerase Chain Reaction (QF PCR) in Prenatal Diagnostic of Fetal Aneuploidies in a 17 Month Period in Parallel with Karyotyping.Acta Inform Med. 2014 Apr;22(2):86-8. 2. Godinjak Z, Bilalovic N.Estrogen and progesterone receptors in endometrium in women with unexplained infertility. Mater Sociomed. 2014 Feb;26(1):51-2. 3. Foco F, Bilalović N, Vranić S, Serdarević F, Ramović I, Imamović E.Peritumoral p53 expression in oral carcinoma. Coll Antropol. 2012 Nov;36 Suppl 2:129-32. 4. Godinjak Z, Bilalović N, Idrizbegović E. Laparoscopic treatment of ovarian dermoid cysts is a safe procedure. Bosn J Basic Med Sci. 2011 Nov;11(4):245-7. 5. Kozarić-Kurtović A, Bilalović N, Gavrankapetanović F. Razvoj citogenetike i molekularne genetike u medicinskoj dijagnostici na Kliničkom Centru Univerziteta u Sarajevu. Med Žurnal 2010; 16 (4, Suppl.1):31-37 6. Obralić N, Kulovac B, Bilalović N, Aganović D. Comparisson of preoperatiove and postoperative stage and grade of prostate carcinoma in patients with PSA level of 2-10 ng/ml. In press LIBRI ONCOLOGY, vol. XXXVI No. 1-3 2008. 7. Vukobrat-Bijedić Z, Husić-Selimović A, Radović S, Gornjaković S, Gogov B, Zubcević N, Bilalović N, Koluder Evaluation of hepatitis C virus genotype and its influence on therapeutical respond on combined therapy with pegilated interferon A 2a (40)kD and ribavirin.med Arh. 2007;61(4):221-3. 8. Vranic S, Caughron SK, Djuricic S, Bilalovic N, Zaman S, Suljevic I, Lydiatt WM, Emanuel J, Gatalica Z. Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinicopathologic correlation, cytogenetic analysis, and review of the literature.bmc Ear Nose Throat Disord. 2008. 9. Sofic A, Sehovic N, Beslic S, Prnjavorac B, Bilalovic N, Caluk J, Sofic D MR rectum imaging with ultra sound gel as instrumental contrast media in tubulovillous adenomaso RADIOLOGY AND ONCOLOGY VL 42 IS 3 BP 136 EP 142 PY 2008 TC 1 10. Fočo F, Vranić S, Serdarević F, Čičkušić E,Bilalović N. Peritumoral expression of p53 protein in oral carcinoma its correlation with relapse. Medicinski Žurnal 2007 13 (3-4): 95-99 11. Lacevic A, Bilalovic N, Kapic A. Bacterial aggregation in infected root canal. Bosn J Basic Med Sci. 2005 Nov;5(4):35-9 12. Bilaloviċ N., Vidoviċ Z., Telemedicine with respect to telepathology in Bosnia-Herzegovina. Med Arh 1999;53:69-72. 13. Vidoviċ Z., Bilaloviċ N., Babiċ M., Selak I., Šimiċ S., Carcinoma of sweat gland vulve, Med Arh 1996;2:40-43. 5.3 Pregledni/revijalni radovi 1. Bilalovic N, Vranic S, Serdarevic F, Foco F. The role of the stroma in carcinogenesis. Bosn J Basic Med Sci 2006;6(1):33-8 5

5.4 Prikazi slučajeva 1. Dizdarević K; Bilalović N, Apok V. Neurosurgical Treatment of Sporadic Meningoangiomatosis. PEDIJATRIJA DANAS. 2010; 6(1):82-86. 2. Cukić V, Lovre V, Beslić S, Bilalović N, Guska S.Lung lymphangioleiomyomatosis (LAM). Med Arh. 2008;62(3):180-2 3. Prohic A, Selmanagic A, Bilalovic N. Epidermolytic Hyperkeratosis Type NPS-3: A Case Report. Acta Dermatovenerol Croat. 2007;15(1):20-3. 4. Vranić S, Kapur L, Fočo F, Bilalović N, Hainaut P. The first case of LiFraumenisyndrome in Bosnia and Herzegovina: Case report. Pathologica2006;98:156-59. 5. Vidoviċ Z., Bilaloviċ N., Babiċ M., Selak I., Šimiċ S., Carcinoma of sweat gland vulve, Med Arh 1996;2:40-43. 5.5 Abstrakti (kongresi, simpoziji, konferencije..) 1. Gatalica Z, Bilalovic N, Palazzo J. P., Bender R. P., Millis S, Hoff D Von, Arceci R. J. Disseminated histiocytoses: biomarkers beyond BRAFV600E. Note:American Society of Clinical Oncology Chicago 2015 2. Udovicic-Gagula D, Ahmovic A, Bilalovic N, Doric M. EXPRESSION OF KI-67 AND ESTROGEN RECEPTOR BETA IN PRIMARY MALIGNANT MELANOMA AS A POTENTIAL INDICATOR OF REGIONAL LYMPH NODE POSITIVITY.Pathology-Journal of the RCPA, 2014 (2014), 46(S2) Note: the XXXth Congress of the International Academy of Pathology - IAP 2014. Bangkok, Thailand October 5-10, 2014 3. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Branzovsky J, Michal M, Hes O. CYSTIC RENAL ONCOCYTOMA AND TUBULOCYSTIC RENAL CELL CARCINOMA: MORPHOLOGIC AND IMMUNOHISTOCHEMICAL COMPARATIVE STUDY. (2014), 46(S313) Note: the XXXth Congress of the International Academy of Pathology - IAP 2014. Bangkok, Thailand October 5-10, 2014 4. Chikha A, Jukovic-Bihorac F, Skenderi F, Krakonja F, Bilalovic N, Vranic S. Infarcted fibroadenoma of the breast: Report of two cases. Histopathology 2012;61(suppl.1):15. Note: XXIX Congress of the International Academy of Pathology. Cape Town, South Africa, September 30 October 5, 2012 5. Bilalović N, Kapetanović A, Chikha A, Hodžić D. APOCRINE CARCINOMA, DOBRO DIFERENCIRANI (SYRINGOCYSTADENOCARCINOMA PAPILLIFERUM) NASTAO U PREEGZISTIRAJUĆEM SYRINGOCYSTADENOMA PAPILLIFERUM I NAEVUS SEBACEUS APOCRINE CARCINOMA WITH GOOD DIFFERENTIATION (PAGE 232). Note:2 CONGRESS OF PATHOLOGISTS IN BOSNIA AND HERZEGOVINA WITH INTERNATIONAL PARTICIPATION 10-12 May 2012, Banja Luka 6. Bilalovic N, Chika A.,Hodžić D.,Torlaković.,Đuričić S.HEMOFAGOCITNI SINDROM HEMO-FAGOCYTIC SYNDROME (PAGE 243). Note:2 CONGRESS OF PATHOLOGISTS IN BOSNIA AND HERZEGOVINA WITH INTERNATIONAL PARTICIPATION 10-12 May 2012, 7. Bilalovic N, Hodzic D, Omanovic A, Vranic S. Granulocytic Sarcoma of the Breast. Abstract Book, 2nd Congress of Pathologists in Bosnia and Herzegovina with international participation; pp 67-68. Note: 2nd Congress of Pathologists in Bosnia and Herzegovina with international participation, Banja Luka, May 10-12, 2012 8. Nurija Bilalović (Sarajevo, BiH): Limfomi probavne cijevi: od morfologije do molekularne biologije. Note:Days of BHAAAS in B&H / Dani BHAAAS u BiH Sarajevo18.04.2012 9. Bilalovic, N, Chika A,Hodžić D,Ibišević N,Torlaković E,Đuričić S. Hemophagocytic syndromes-a case report."histopathology. Vol. 61. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2012Note: The International Academy of Pathology Cape Town 2012 10. Bilalovic, N, Hodzic D, Kurtovic-Kozaric A, Omanovic A, Chika A, Ibisevic N, Vila M, Hafizovic A.S. Myeloid sarcoma: unusual presentation of four cases. In HISTOPATHOLOGY, vol. 61, pp. 115-116. 111 RIVER ST, HOBOKEN 07030-5774, NJ USA: WILEY-BLACKWELL, 2012. Note: The International Academy of PathologyCape Town 2012 6

11. Vranic S, Frkovic-Grazio S, Bilalovic N, Gatalica Z. Evaluation of angiogenesis in adenoid cystic carcinoma of the breast. Virchows Arch 2011;459(suppl.1):S84. Note: 23rd European Congress of Pathology, Helsinki, Finland, August 27 September 1, 2011 12. Bilalovic N. Patološki i biološki markeri karcinoma dojke - prognostički i prediktivni značaj. Note: Symposium Savremeni pristup u tretmanu karcinoma dojke, Akademija nauka i umjetnosti Bosne i Hercegovine, November 23, 2011 13. Nurija Bilalovic Needle Biopsy for Noninvasive and Invasive Breast Cancer.Note: 4. Kongres radiologa BiH sa međunarodnim učešćem 30.09. -20.10. 2011 14. Vranic S, Frkovic-Grazio S, Bilalovic N, Palazzo J, Gatalica Z. Epidermal Growth Factor Receptors And Topoisomerase II Alpha In Primary Adenoid Cystic Carcinomas Of The Breast. Mod Pathol 2010;23(Suppl.1):76A. Note: United States & Canadian Academy of Pathology Annual Meeting, Washington DC, USA, March 20-26, 2010 15. Merhemić Z, Gavrankapetanović F, Bilalović N, Nikšić M, Kadenić Z, Avdagić E, Thurnher MM. Comparision of 1.5 and 3.0 T Diffusion-Weighted MR Imaging for Brain Tumors. Symposium neuroradiologicum: the world congress of diagnostic and therapeutic neuroradiology, 19th.: Communications; Bologna, Italy. Bologna: s.n.; 2010: 148(full). Notes: The NEURORADIOLOGY JOURNAL, formerly RIVISTA DI NEURORADIOLOGIA, 2010: 148 (full) 16. Dizdarevic K, Omerhodzic I, Bilalovic N. INTRACRANIAL MENINGIOANGIOMATOSIS: A CASE REPORT. FOLIA MEDICA FACULTATIS MEDICINAE UNIVERSITATIS SARAEVIENSIS 2009;44(14-suppl) Note:Morfologija u nauci i praksi" sa međunarodnim učešćem, 23.-25. septembar 2009., Sarajevo, Bosna i Hercegovina 17. Kundurovic Z, Hasanagic S, Bilalovic N, Gavrankapetanovic F. EXPRESSION OF CERTAIN MEMBERS OF BCL-2 FAMILY OF ONCOPROTEINS IN STREPTOZOTOCIN MODEL OF ALZHEIMER S DISEASE 2009;44(28-suppl) Note:Morfologija u nauci i praksi" sa međunarodnim učešćem, 23.-25. septembar 2009., Sarajevo, Bosna i Hercegovina 18. Merhemić Z, Gavrankapetanovic F, Beslija S, Bilalović N, Thurnher MM. Diffusion-weighted MR imaging(dwi) in evaluation of brain tumors: comparasion 1,5 T vs.3.0 T. Neuroradiology (2009) 51 (Suppl 1):99 1. Note 18th Advanced Course& 2nd International Advanced Course, September 17-20, Athens, Greece 19. Hasanagic S, Kundurovic Z, Kucukalic A, Gavrankapetanovic F, Bilalovic N, Petrisic-Salkovic M, RiedererP. Expression of certain apoptotic regulators in a pharmacological experimental model of Alzheimer's disease. The Journal of the European College of Neuropsychopharmacology 2009; 19 ( 3): 625-1. 20. Lojo-Kadrić N, Kapur L, Ramić J, Bešlija S, Obralić N, Bilalović N, Vranić S, Bajrović K. Identifikacija mutacija na BRCA1 genu u skupini pacijenata sa dijagnozom karcinoma dojke i ovarija prije 40 te godine života. Note: International Scientific Symposium Molecular genetic research today and it's application possibilities. Tuzla, October 11, 2008 21. Ramić J, Kapur L, Lojo Kadrić N, Macić D., Radić K., Bilalović N., Bajrović K.Ekspresija BRCA1 I TP 53 u različitim tipovima tumorskog tkiva (Expression of BRCA1 and TP 53 genes in different types of tumor). Note: MOLECULAR GENETICS RESEARCH TODAY AND IT'S APPLICATION POSSIBILITIES. Tuzla,11. oktobar 2008. 22. Kapur Poljskic L, Lojo Kadic N, Ramic J, Macic D, Bilalovic N, Obralic N. Cancer tissue database for the purpose of genetic epidemiology of breast cancer in Bosnia and herzegovina. BOUN Journal 2008; 13, Suppl 1: 15 (abstract PP-34) 23. Bilalovic N, Cimic A, Lazovic E, Cvorak A.CUTANEOUS ROSAI DORFMAN DISEASE WITHOUT LIMPHADENOPATHY A CASE REPORT. Note:Congress dermatovenerology 23.- 26. maja 2007, Sarajevo, BiH 24. Lazovic E, Bilalovic N, Cimic A, Bukvic I. DISTANT METASTATIC DISEASE OF SKIN MELANOMA AT OVARY, LIKE PARAOVARY CYST: CASE REPORT. Note:Congress dermatovenerology 23.- 26. maja 2007, Sarajevo, BiH 25. Vranić S., Đuričić S., Suljević I., Bilalović N. Unrecognized epignathus followed by airway obstruction as a cause of neonatal death. Acta Clin Croat 2007;46 (suppl. 2):23. Note :17 th Ljudevit Jurak International Symposium on comparative pathology, Juni 1-2, 2007 Zagreb, Croatia 7

26. Vranić S, Bilalović N, Ćerimagić Z, Gatti A, Kayser K. Secondary leiomyomatosis in a Bosnian male: A case report. Acta Clin Croat 2006;45(2):163 Note: 17th Ljudevit Jurak International Symposium on Comparative 8 Pathology, Zagreb, Croatia, June 2-3, 2006 27. Kundurovic Z, Hasanagic S, Salkovic-Petrisic M, Bilalovic N, Riederer P. Indications of apoptotic cascade activation in temporal gyrus neurons of rats with experimental cerebral diabetes. Germany Journal of Neural Transmission. 2007. VL 114. 26-1. Note: 39th International Danube Symposium for Neurological Science and Continuing Education/1st International Congress on ADHD, from Childhood 28. Ibrulj, S. Heljic S, Bilalovic N. The spectrum of abnormalities in child with de grouchy syndrome type 2. Chromosome Research (2007);15:51-1. Note: CT 6th European Cytogenetics Conference JUL 07-10, 2007 Istanbul, TURKEY 29. Brigić E., Mesihović R., Sabina Kurtagić S., Dizdarević,Brigić A., Bilalović N., Koressov model kancerogeneze i djetinjstvo. Note:Treći kongres pedijatara Mostar 24-27.10.2007 30. Cimic A, Vranic S, Bilalovic N. Virchows Arch 2007; Intraabdominal localization of extraskeletal myxoid chondrosarcoma: Case report. Virchow's Archive. Virchow's Archive. 2007; 451( 2):573-1. Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, 2007 31. Vranic S, Cimic A, Pasanovic A, Hodzic D, Bilalovic N. Cyclin D1 and Ki-67 expression in columnar cell lesions of the breast. Virchows Arch Virchow's Archive. 2007; 451( 2):296-1. Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, 2007 32. Bilalovic N, Cimic A, Vranic S, Vidovic Z, Kayser K. Pulmonary papillary pneumocytoma (sclerosing hemangioma) and importance of clinical data. Virchow's Archive. Virchow's Archive. 2007; 451( 2): 529-1. Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, 2007 33. Bilalovic N, Cimic A, Vranic S, Bejtovic I, Chikha A, Gavrankapetanovic F. Endoglin (CD105) expression in nonsmall cell lung cancer and its correlation with EGFR, CD34 and other histopathological parameters: Pilot study. Virchow's Archive. 2007; 451( 2):528-1. Note: 21st European Congress of Pathology, Istanbul, Turkey, September 8-13, 2007 34. Gatalica Z., Lee L., Hatcher L., Palazzo J.,Adegboyega P.,Tawfik O. Bilalovic N. Pure apocrine carcinomas of the breast overexpress EGFR and have increased EGFR gene dosage due to polysomy of chromosome Modern Pathol., 2007;Vol 20:(Suppl 2).32-1. Note:UNITED STATES AND CANADIAN ACADEMY OF PATHOL OGY,March 24-30, 2007 San Diego, California 35. Fočo F, Vranić S, Serdarević F, Čičkušić E, Gurjeva O, Bilalović N. Peritumoral expression of p53 in oral cancer and its correlation with relapse. Oral Oncol Suppl 2007.172-1. 36. Vranić S, Lazovic E, Obralic N, Gavrankapetanovic F, Bilalovic N. The correlation of morphological features of transitional cell carcinoma of urinary bladder with different biological parameters. Modern Pathol.2006;19(Suppl.3):88-2. Note:XXVI IAP International Congress, September 16-21, 2006 Montreal, Canada. 37. Vranić S, Muftić K, Bešlić,Bilalović N. Reccurent malignant granular cell tumor of the breast: A case report. Modern Pathol. 2006;19 (Suppl. 3) :26-26. Note:XXVI IAP International Congress, September 16-21, 2006 Montreal, Canada. 38. Bilalović N, Šeparović R, Hiroš M, Perić-Balja M, Krušlin B. Adenoid cystic carcinoma of breast metastazing to the kidney: a case report. Modern pathology.2006; Vol 19( Suppl 3):77-1. Note:XXVI IAP International Congress, September 16-21, 2006 Montreal, Canada. 39. Vranic S, Tanovic H, Lazovic E, Pasanovic A, Bilalovic N.Abdominal anaplastic large cell lymphoma with spleen and pancreas involment. Note:First congress of surgery of Federation of Bosnia and Herzegovina. Sarajevo 12-15. April 2006. 40. Bilalovic N, Tanovic M, Adrovic A, Kukavica M, Vranic S.Expression of Cyclin D1in human colorectal cancer (CRC) and its correlation with prognosis. Note:First congress of surgery of Federation of Bosnia and Herzegovina. Sarajevo 12-15. April 2006 8

41. Balta E,Bešlić N, Bilalović N, Šečić S, Kapetanović E, Muftić K. SLN operativna tehnika malignih tumora dojke. Note:First congress of surgery of Federation of Bosnia and Herzegovina. Sarajevo 12-15. April 2006. 42. Torlakovic E, Slipicevic A, Florenes V, Chibbar R, Bilalovic N. Fli-1 Expression in Malignant Melanoma. Lab Invest 2006;86(Suppl.1):88-1. Note:UNITED STATES AND CANADIAN ACADEMY OF PATHOL OGY, February 11-17, 2006, Atlanta, Georgia. 43. Torlakovic E, Bilalovic N, Glolouh R, et al. Prognostic significance of germinal center (GC) phenotype for outcome in follicular lymphoma. Lab Invest 2005;85(Suppl.1):254-1. Note:UNITED STATES AND CANADIAN ACADEMY OF PATHOL OGY, February 11-17, 2006, Atlanta, Georgia. 44. Vuckovic I, Dilberovic F, Obhodzas M, Bilalovic N. Intrafascicular application of Lidocaine 2% or 0.9% NaCl into the medianus nerve of the rat. Reg Anesth Pain Med 2005; 30(3):43-1 45. Bilalovic N, Vranic S. Expression of CD10 in stromal fibroblast in invasive breast cancer. Virchow. 2005; 447 (2);14-1.Note:20th European Congress of Pathology, Paris, September 2005 46. BILALOVIC N, Vranic S. Expression of CD34 as a vascular marker in invasive breast cancer. Book of Abstracts.Note:3 rd Croatian Congress of Pathology, Forensic Medicine, Clinical Cytology in Opatija, Croatia, 8-11 May 2005. 47. Bilalović N.,Hasanagić S., Vranić S., Bešlija S., Bašić H., Selak I. Although Bcl-2 expression is associated with better outcome, Bcl-2 is not independent prognosticator of overall survival (OS) and relapse-free survival (RFS) in breast cancer. Eur J Cancer Suppl 2004;3(2):180-1. 48. Vranić S, Bilalović N. Cyclin D1 expression in breast cancer. Abstractbook of «15th ESC», Berlin, Germany, October 19-23, 2004. 49. Bilalovic N, Vranic S, Hasanagic S, Basic H,Tatarevic A, Selak I. Cyclin D1 is good prognosticator in breast cancer, Acta clinica Croatica 2004;Vol 43(2): 93-1.(rad nagrađen kao najbolji rad simpozijuma). Notes:15 th Ljudevit Jurak International Symposium on comparative pathology, Juni 4-5, Zagreb, Croatia 50. Bilalovic N, Vranic S., Hasanagic S., Selak I. Epstein-barr virus expression in breast cancer Acta clinica Croatica 2004;Vol 43(2),92-1. Notes:15 th Ljudevit Jurak International Symposium on comparative pathology, Juni 4-5, Zagreb, Croatia 51. Basic H, Bilalovic N, Vranic S, Tatarevic A. Estrogen and Progesterone receptor expression more precisely determined by monoclonal H-score immunohistochemistry than by polyclonal antibodies, impact on breast cancer outcome. Cancer control in developing countries, 2004: 42-1. Notes: Annual Meeting 2004, Cancer control in developing countries, Translating Knowledge into Effective Action, Cairo, Egypt, October 2 nd -5 th, 2004 52. Basic H, Bilalovic N, Tatarevic A, Vranic S. Correlation between the prognostic value of Bcl-2 and standard clinical and histopathological parametres in breast cancer patients. Ann Oncol 2004;15(Suppl.3):iii58 (No. 219P). ANNALS OF ONCOLOGY 15, 58-58. Notes: 29th ESMO Congress, Vienna, Austria, 29.Oct-2.Nov. 2004 53. Bilalovic N., Anne Kirsti Blystad, Golouh R., Nesland J.M., Selak I., Torlakovic E. Prognostic value of grading in follicular lymphoma.notes: Morphology in science and praxis, Sarajevo, September 25-27, 2003 54. Bilalovic N., Berbic-Fazlagic J., Robovic Z., Vranic S., Cikic B., Selak I. Immunohistochemical analysis significance in diagnostic assessment of malignant lymphoma.notes: Morphology in science and praxis, Sarajevo, September 25-27, 2003 55. Bilalovic N., Golouh R., Nesland J.M., Selak I., Torlakovic E. BCL-6 and CD10 protein expressions are prognostic factors of overall survival and time to treatment failure in follicular lymphoma. Virchows Archiv, Volume 443, Number 3,2003, Pages: 241 489.Notes: 19th ECP, Ljubljana, Slovenia, September 6-11, 2003. 56. Bilalovic N., Golouh R., Nesland J.M., Selak I., Torlakovic E. Follicular lymphoma grading by Mann and Berard are predictive of overall survival and time to treatment failure, however, only grade 1 has favorable OS and TTF. Virchows Archiv, Volume 443, Number 3,2003Pages: 241-489Notes: 19th ECP, Ljubljana, Slovenia, September 6-11, 2003. 57. Bilalovic N., Golouh R., Nesland J.M., Selak I., Torlakovic E. In malignant melanoma CD10 protein expressions 9

is associated with metastatic tumors higher Clark levels and tumor thickness according to Breslow. Virchows Archiv, Volume 443, Number 3,2003, Pages: 241-489Note: 19th ECP, Ljubljana, Slovenia, September 6-11, 2003. 58. Vuckovic I, Mulabdic V, Bilalovic N. Telemedicine in relation to telepathology in Bosnia and Herzegovina Note: First Congress of Medical Informatics, Sarajevo 6th World Congress on the Internet in Medicine. 59. Bilaloviċ N., Selak I., Taccagni G.,Paties C., Fontanella G.SHARED (Satellite Health Access for Remote Environment Demonstrator), project in Bosnia and Herzegovina: benefits of using telemedicine and first results. Journal of Telemedicine and Telecare1998;4:91-3. Notes: Royal Society of Medicine, London, 26. November 1997. 60. Bilaloviċ N., Babiċ M., Selak I., Taccagni G.,Paties C., Fontanella G., 1997. Telemedicine project (SHARED) in R/F Bosnia and Herzegovina : First results of its use in histopathological diagnosis, Analytical Cellular Pathology Notes :( AWARDED IN OSLO ON THE 5 CONGRESS ESACP) 61. Mornjakoviċ Z., Aličelebiċ S., Bilaloviċ N., Šuško I.,Morphometric characteristics of Leydig cells in rats treated with melatonin and whole body irradiation. Notes: 7th European Congress for stereology. Amsterdam 20-23, April 1998 62. Selak I., Bilaloviċ N.Concept of Telepathology in R/F Bosnia and Herzegovina, Electronic Journal of Pathology and Histology.Notes: Second Congress of Telepathlogy, Zagreb 1996. 6. Objavljene publikacije (knjige, udžbenici, monografije, vodiči, praktikumi) Naziv publikacije Obralić N. REGISTAR MALIGNIH NEOPLAZMI KLINIČKOG CENTRA UNIVERZITETA U SARAJEVU: 2003-2007. & ANALIZA PODATAKA ZA PERIOD 1998.-2007. Autor/autori Gavrankapetanović F; Gavrankapetanović I; Bilalović N; Jurić N; Selak I; Radović S; Žutić H; Bešlić Š; Gribajčević M; Junuzović Dž; Tanović H; Kandić Z; Kapidžić A; Kadić N; Dizdarević K; Alender F; Hujić H; Mesihović-Dinarević S; Hadžismajlović A; Piranić H; Mesihović R; Alikadić-Husović A; Fazlić A; Bukvić I; Lončarević N, and Bijedić V Izdavač Vrsta publikacije INIRR Sarajevo znanstveno / stručna knjiga Godina izdavanja 2008 7. Ostvareni projekti (navoditi od posljednjeg ostvarenog projekta) Naziv projekta Vrsta projekta (stručni, naučniistraživački, Prognostička i prediktivna vrijednost imunohistohemijskog određivanja proteina u karcinomu želuca 2010 voditelj domaći Naučnoistraživački Kantonalno Ministarstvo za obrazovanje, nauku, kulturu i sport 10

Naziv projekta Vrsta projekta (stručni, naučniistraživački, Banka sperme 2010 učesnik domaći Naučnoistraživački Kantonalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Vrsta projekta (stručni, naučniistraživački, Osnivanje i razvoj tumorske banke 2008 učesnik Domaći Naučnoistraživački Federalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Vrsta projekta (stručni, naučniistraživački, Učestalost i kliničko-patološki značaj koegzistentnih (istovremenih) mutacija PIK3CA i PTEN gena u grupi invazivnih karcinoma dojke sa bazalnim fenotipom 2007 voditelj Domaći Naučnoistraživački Kantonalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Uloga i prognostički značaj stromalnih fibroblasta u invazivnom karcinomu dojke. 2004 učesnik Domaći 11

Vrsta projekta (stručni, naučniistraživački, Naučnoistraživački Federalno Ministarstvo za obrazovanje, nauku, kulturu i sport Naziv projekta Vrsta projekta (stručni, naučniistraživački, Značajimunohistohemijeikliničkihpodatakaudijagnosticimalignihlimfomaklasificiranih por.e.a.l.- Reviziji Evropsko Američke Limfoma Klasifikacije 2001 učesnik Domaći Naučnoistraživački Akademija nauka i umjetnosti BiH Naziv projekta Vrsta projekta (stručni, naučniistraživački, Detekcija Epstein-Barr virusa (EBV) u Hodgkin i non-hodgkin lymphoma u Sarajevskoj regiji.. 2002 učesnik Domaći Naučnoistraživački Akademija nauka i umjetnosti BiH Naziv projekta Vrsta projekta (stručni, naučniistraživački, SHARED / Satelite Health Access for Remote Environment Demonstrator /, telemedicinski projekat baziran na videokonferencijama i videokonsultacijama između San Raffaele Hospital, Milano i Kliničkog Centra, Univerziteta u Sarajevu. 1996-1998 voditelj Međunarodni Naučnoistraživački-eksperimentalni San Raffaele International Biomedical Science Park sa Stato Maggiore della diffesa and European Space Agency 12

8. Mentorstvo (magisteriji, doktorati) Ime i prezime kandidata Naziv teme Husein Čamo KLINIČKI IMUNOFENOTIPSKI PROGNOSTIČKI MARKERI U SOFT TISSUE TUMORIMA Datum odbrane 23.10.2014 Fakultet/Univerzitet Magisterij/Doktorat Prirodno- matematički fakultet Univerziteta u Sarajevu Magisterij 9. Radionice, tečajevi Naziv Bosnian-British School of Pathology (Bryan Warren School of Pathology) Datum 2007-2014 Organizator Voditelj/učesnik British Division of the International Academy of Pathology (BDIAP), United Kingdom and Department of Pathology, Clinical Centre of the University of Sarajevo,Bosnia and Herzegovina Voditelj Naziv Datum Organizator Voditelj/učesnik European Bone Marrow Working GroupBusiness meeting 25-26th June 2006, London, Museum at Charing Cross Hospital,Fulham Palace Road W6 8 RF European Bone Marrow Working Group Učesnik Naziv Datum Pathology of the digestive system: A EuroAmerican course June 16.-18. 2005, Geneva, Switzerland Organizator Voditelj/učesnik Učesnik Naziv Tutorial of Haematopathology Datum Pecs, Hungary, between 9-12 April 2001 Organizator Voditelj/učesnik European Association for Hematopathology Učesnik Naziv Tutorial on the Use of New Techniques in Diagnosis of Malignant Lymphomas Datum Ljubljana 2-5 February 1998 Organizator Institute of Oncology Ljubljana and Medical Center for Molecular Biology of Medical 13

Faculty University of Ljubljana Voditelj/učesnik Učesnik Naziv Datum Organizator Voditelj/učesnik Twenty-first International Tutorial on Clinical Cytology Decembar 5-12,1998, Vienna, Austria The Austrian Society of applied Cytology, The American Society of Cytopatology, The European Federation of Cytology Societies, The International Union Against cancer (UICC), The Royal College of Pathologists (UK) Učesnik 10. Poznavanje stranog jezika (EU CEFR) Jezik A1 A2 ( osnovno služenje jezikom) B1 B2 (samostalno služenje jezikom) C1 C2 (kompetentno služenje jezikom) C1-C2 11. Saradnja sa institucijama relevantnim za stručnu ili naučnu oblast General Surgical Pathology, Department of Pathology, Oncology Institute, Ljubljana, Slovenia Department of Pathology, The Norwegian Radium Hospital, Oslo, Norway Toronto General Hospital, Ontario, Canada 12. Predavanja po pozivu Tema Datum Mjesto Institucija 1. 12th Annual Congress of International Drug Discovery Science & Technolog chair in the Session 1162: Infertility & Sterility of the Section 11-6: Women Health while presentingaboutestrogen and Progesterone Recepto rs in Endometrium in Women with Unexplained Infertility November 18-20, 2014 Tongli Lakeview Hotel, Suzhou, China Organizing Committee of IDDST-2014 2. Ekstranodalni limfomi 15. jun 2012 Beograd Uruženje patologa i citologa Srbije 3. Ljetna pedijatrijska škola Sarajevo KLINIČKI ZNAČAJ POVEĆANJA INTRAEPITELNIH LIMFOCITA U DUODENUMU 30.05.2014.- 31.05.2014 Sarajevo Pedijatrijska Klinika Sarajevo 14

13. Recenzije i uredništvo u domaćim i međunarodnim knjigama i časopisima(upisati) Naziv knjige Godina izdavanja Recenzija knjige VODIČ ZA TRETMAN MALIGNOG MELANOMA I PIGMENTNIH PROMJENA KOŽE 2008 Naziv časopisa Broj Recenzija rada Medical Journal (2014) Vol. 20, No. 3, 200-202 Recenzija rada Medical Journal (2014) Vol. 20, No. 4, 252-255 Naziv publikacije Period obavljanja funkcije /Datum Uredništvo publikacija Glavni/odgovorni urednik Član redakcijskog odbora Član naučnog odbora 14. Priznanja i pohvale Bilalovic N, Vranic S, Hasanagic S, Basic H,Tatarevic A, Selak I. Cyclin D1 is good prognosticator in breast cancer, Acta clinica Croatica 2004;Vol 43(2): 93-1.(rad nagrađen kao najbolji rad simpozijuma). Notes:15 th Ljudevit Jurak International Symposium on comparative pathology, Juni 4-5, Zagreb, Croatia Bilaloviċ N., Babiċ M., Selak I., Taccagni G.,Paties C., Fontanella G., 1997. Telemedicine project (SHARED) in R/F Bosnia and Herzegovina : First results of its use in histopathological diagnosis, Analytical Cellular Pathology Notes :( AWARDED IN OSLO ON THE 5 CONGRESS ESACP) Svojim potpisom odgovorno potvrđujem da su svi podaci koji su objavljeni u Naučnom kartonu pod mojim imenom u cijelosti tačni i provjerljivi Datum Potpis 30.01.2015 Doc. Dr. Nurija Bilalović 15